GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (XPAR:GNRO) » Definitions » Short-term investments

GeNeuro (XPAR:GNRO) Short-term investments


View and export this data going back to 2016. Start your Free Trial

What is GeNeuro Short-term investments?

Short-term investments only applies to insurance companies.


GeNeuro Business Description

Traded in Other Exchanges
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).